allopurinol and Cognitive-Dysfunction

allopurinol has been researched along with Cognitive-Dysfunction* in 2 studies

Other Studies

2 other study(ies) available for allopurinol and Cognitive-Dysfunction

ArticleYear
Xanthine oxidase mediates chronic stress-induced cerebrovascular dysfunction and cognitive impairment.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2023, Volume: 43, Issue:6

    Xanthine oxidase (XO) mediates vascular function. Chronic stress impairs cerebrovascular function and increases the risk of stroke and cognitive decline. Our study determined the role of XO on stress-induced cerebrovascular dysfunction and cognitive decline. We measured middle cerebral artery (MCA) function, free radical formation, and working memory in 6-month-old C57BL/6 mice who underwent 8 weeks of control conditions or unpredictable chronic mild stress (UCMS) with or without febuxostat (50 mg/L), a XO inhibitor. UCMS mice had an impaired MCA dilation to acetylcholine vs. controls (p < 0.0001), and increased total free radical formation, XOR protein levels, and hydrogen peroxide production in the liver compared to controls. UCMS increased hydrogen peroxide production in the brain and cerebrovasculature compared to controls. Working memory, using the y-maze test, was impaired (p < 0.05) in UCMS mice compared to control mice. However, blocking XO using febuxostat prevented the UCMS-induced impaired MCA response, while free radical production and hydrogen peroxide levels were similar to controls in the liver and brain of UCMS mice treated with febuxostat. Further, UCMS + Feb mice did not have a significant reduction in working memory. These data suggest that the cerebrovascular dysfunction associated with chronic stress may be driven by XO, which leads to a reduction in working memory.

    Topics: Animals; Cardiovascular Physiological Phenomena; Cerebrovascular Circulation; Cerebrovascular Disorders; Cognitive Dysfunction; Enzyme Inhibitors; Febuxostat; Free Radicals; Hydrogen Peroxide; Memory, Short-Term; Mice; Mice, Inbred C57BL; Stress, Psychological; Xanthine Oxidase

2023
Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.
    Journal of Alzheimer's disease : JAD, 2015, Volume: 47, Issue:4

    Only a limited number of studies have investigated the decline of discrete cognitive domains as individuals progress from mild cognitive impairment (MCI) to dementia. Thus, the goal of this longitudinal study was to evaluate the cognitive changes underway during the years preceding a diagnosis of probable Alzheimer's disease (AD), and to compare these changes to those found in MCI participants who do not progress to dementia. Participants were compared as a function of whether they later converted to AD (n = 47) or not (n = 74). Cognitive change was assessed prior to the conversion year, using that year as a starting point. A combination of polynomial regression analyses and mixed ANOVAs assessed 1) the trajectory of cognitive decline for each domain and 2) the differences between non-progressors and those who had converted to AD. The different cognitive domains demonstrated very different patterns of decline in the group of MCI progressors. A quadratic function, i.e., many years of stable performance followed by a rapid decline just prior to diagnosis, was observed for delayed recall, working memory, and spatial memory. In contrast, a gradual linear decline was observed for immediate recall, executive function, and visuo-spatial abilities. Finally, language in progressors was impaired on all time periods relative to non-progressors, but there was no further change between the first assessments and conversion to AD. Individuals with MCI who progress to AD show abnormal cognition at least two years prior to their dementia diagnosis. The pattern of symptom change observed appears to depend upon the cognitive domain and thus, clinical studies should not assume similar rate of decline across domains. In contrast and, apart from verbal memory, the non-progressors present a performance similar to that of healthy older adults.

    Topics: Aged; Allopurinol; Alzheimer Disease; Cognition; Cognitive Dysfunction; Disease Progression; Executive Function; Female; Follow-Up Studies; Humans; Language; Longitudinal Studies; Male; Memory, Short-Term; Mental Recall; Neuropsychological Tests; Retrospective Studies; Spatial Memory

2015